Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
11 studies found for:    "Peyronie disease"
Show Display Options
Rank Status Study
1 Completed Peyronie's Disease Treatment Protocol
Condition: Peyronie's Disease
Interventions: Drug: H-100;   Drug: Placebo
2 Completed Study of AA4500 in the Treatment of Peyronie's Disease
Condition: Peyronie's Disease
Intervention: Biological: AA4500
3 Completed Study of AA4500 in the Treatment of Peyronie's Disease
Condition: Peyronie's Disease
Intervention: Biological: AA4500
4 Completed A Study of AA4500 in Men With Peyronie's Disease
Condition: Peyronie's Disease
Intervention: Biological: AA4500
5 Completed
Has Results
The Safety and Effectiveness of AA4500 in Subjects With Peyronie's Disease
Condition: Peyronie's Disease
Interventions: Biological: AA4500;   Biological: Placebo
6 Recruiting An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease
Condition: Peyronie's Disease
Interventions: Biological: AA4500;   Device: ErecAid® Esteem® Manual Vacuum Therapy System;   Procedure: Investigator Modeling
7 Completed A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease
Condition: Peyronie's Disease
Intervention: Biological: AA4500
8 Recruiting H-22411: BOTOX® for Peyronie's Disease
Condition: Peyronie's Disease
Interventions: Drug: 100 units of BOTOX®;   Other: Preservative free normal saline
9 Completed Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease
Condition: Peyronie's Disease
Intervention: Biological: AA4500
10 Recruiting Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease
Condition: Peyronie's Disease
Interventions: Drug: Vitamin D2;   Drug: Vitamin E;   Drug: Testosterone Pellets
11 Enrolling by invitation Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease
Condition: Peyronie's Disease
Intervention: Drug: Subjects Previously Treated with AA4500

Indicates status has not been verified in more than two years